Amphetamine, past and present--a pharmacological and clinical perspective.
Heal DJ, Smith SL, Gosden J, Nutt DJ.
J Psychopharmacol. 2013 Jun;27(6):479-96. doi: 10.1177/0269881113482532. Epub 2013 Mar 28.
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
Siefried KJ, Acheson LS, Lintzeris N, Ezard N.
CNS Drugs. 2020 Apr;34(4):337-365. doi: 10.1007/s40263-020-00711-x.
D-amphetamine maintenance therapy reduces cocaine use in female rats.
Ndiaye NA, Allain F, Samaha AN.
Psychopharmacology (Berl). 2022 Dec;239(12):3755-3770. doi: 10.1007/s00213-022-06271-w. Epub 2022 Nov 11.
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Steinkellner T, Freissmuth M, Sitte HH, Montgomery T.
Biol Chem. 2011 Jan;392(1-2):103-15. doi: 10.1515/BC.2011.016.
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin FR, Fidalgo TM.
Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255. doi: 10.1007/s00213-020-05563-3. Epub 2020 Jun 29.
Pharmacotherapy for amphetamine dependence: A systematic review.
Lee NK, Jenner L, Harney A, Cameron J.
Drug Alcohol Depend. 2018 Oct 1;191:309-337. doi: 10.1016/j.drugalcdep.2018.06.038. Epub 2018 Aug 22.
Treatment for amphetamine withdrawal.
Shoptaw SJ, Kao U, Heinzerling K, Ling W.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003021. doi: 10.1002/14651858.CD003021.pub2.
Nystagmus among suspected amphetamine impaired drivers.
Strand MC, Gjerde H, Høiseth G.
J Forensic Leg Med. 2023 Apr;95:102502. doi: 10.1016/j.jflm.2023.102502. Epub 2023 Mar 4.
Amphetamine abuse.
Ellinwood EH, Cohen S.
Science. 1971 Jan 29;171(3969):420-1. doi: 10.1126/science.171.3969.420.
Lisdexamfetamine dimesylate.
Elia J, Easley C, Kirkpatrick P.
Nat Rev Drug Discov. 2007 May;6(5):343-4. doi: 10.1038/nrd2315.
